| Literature DB >> 32669769 |
Vijay Pratap Singh1, Bidita Khandelwal2.
Abstract
CONTEXTEntities:
Keywords: Anxiety; depression; exercise; exercise self-efficacy; quality of life; yoga
Year: 2020 PMID: 32669769 PMCID: PMC7336951 DOI: 10.4103/ijoy.IJOY_45_19
Source DB: PubMed Journal: Int J Yoga ISSN: 0973-6131
Figure 1CONSORT flow diagram of participants' allocation, intervention, dropouts, follow-up, and analysis
General classes of oral hypoglycemic agents and other drugs taken by participants in all groups during study
| Type of drugs | Yoga ( | Control ( |
|---|---|---|
| Metformin | 99 | 98 |
| Sulfonylureas | ||
| Glimepiride | 11 | 09 |
| Glibenclamide | 10 | 13 |
| Alpha-1-glucosidase inhibitor | ||
| Acarbose | 09 | 12 |
| Voglibose | 22 | 20 |
| GLP-1 agonists | ||
| Sitagliptin | 05 | 10 |
| Vildagliptin | 07 | 11 |
| Glitazones | ||
| Pioglitazone | 07 | 11 |
| Statins | 45 | 43 |
| Vitamin supplements | 75 | 77 |
GLP-1=Glucagon-like peptide-1
Demographic, anthropometric measures and baseline characteristic of the yoga and control groups
| Characteristics | Yoga group (101) | Control group (99) | Baseline association |
|---|---|---|---|
| Gender | |||
| Male:female | 41:60 | 49:50 | 0.001 |
| Age (years) | |||
| Mean±SD | 50.3±9.1 | 49.4±8.7 | 0.049 |
| Range (years) | 23-73 | 29-72 | |
| Education | |||
| Middle school | 11 | 00 | 1.000 |
| High school | 10 | 08 | 0.000 |
| Intermediate | 27 | 20 | 1.000 |
| Graduate/PG | 32 | 37 | 1.000 |
| Professional | 21 | 34 | 1.000 |
| Occupation | |||
| Skilled worker | 06 | 00 | 1.0 |
| Clerk, shop owner, farmer | 30 | 32 | 0.000 |
| Semi-professional | 30 | 26 | 0.000 |
| Professional | 35 | 41 | 1.000 |
| Income (INR) | |||
| 11,817-15,753 | 05 | 28 | 1.000 |
| 15,754-31,506 | 30 | 27 | 0.001 |
| ≥31,507 | 67 | 44 | 1.000 |
| Socioeconomic status | |||
| Lower middle (11-15) | 00 | 08 | 1.000 |
| Upper middle (16-25) | 77 | 50 | 1.00 |
| Upper class (26-29) | 24 | 41 | 0.01 |
| Duration of diabetes (years) | |||
| 1-2 | 33 | 36 | 0.05 |
| 3-4 | 21 | 36 | 0.08 |
| 5-6 | 30 | 18 | 1.0 |
| ≥7 | 17 | 09 | 0.25 |
| Family history of diabetes | |||
| Yes | 33 | 25 | 0.000 |
| No | 68 | 74 | 0.000 |
| Tobacco use | |||
| Yes | 58 | 86 | 0.000 |
| No | 43 | 13 | 1.000 |
| Smoking | |||
| Yes | 68 | 98 | 1.0 |
| No | 33 | 01 | 1.000 |
| Alcohol | |||
| Yes | 95 | 99 | 0.004 |
| No | 06 | 00 | 1.000 |
| Height (cm) | 160.4±6.9 | 158.2±6.1 | 0.000 |
| Weight (kg) | 72.1±8.3 | 65.6±10.9 | 0.06 |
| BMI (kg/m2) | 28.2±4.3 | 26.3±4.6 | 0.039 |
| SBP (mmHg) | 126.0±5.4 | 129.0±5.4 | 0.000 |
| DBP (mmHg) | 82.1±2.6 | 83.7±2.6 | 0.000 |
| HbA1c (%) | 8.6±0.6 | 7.7±1.0 | 0.05 |
| FBS (mg/dl) | 319.4±102.8 | 283.8±102.3 | 0.07 |
| PPBS (mg/dl) | 434.1±108.2 | 386.6±84.5 | 1.000 |
| TC (mg/dl) | 182.5±29.6 | 172.6±34.1 | 1.000 |
| TGs (mg/dl) | 208.1±6.0 | 226.2±6.1 | 1.00 |
| LDL (mg/dl) | 136.9±10.4 | 145.1±9.4 | 1.00 |
| HDL (mg/dl) | 35.8±9.0 | 43.1±9.6 | 1.00 |
| SSI | 37.5±6.7 | 32.0±10.2 | 0.05 |
| STAI | 32.4±6.5 | 24.7±8.2 | 1.00 |
| Total anxiety | 69.9±8.2 | 56.7±12.8 | 0.05 |
| BDI | 23.2±4.3 | 24.8±4.8 | 0.000 |
| Self-efficacy | 31.1±9.9 | 35.2±9.6 | 0.02 |
| D-QOL | 46.9±5.4 | 48.5±8.2 | 0.000 |
SBP=Systolic blood pressure, DBP=Diastolic blood pressure, BMI=Body mass index, FBS=Fasting blood sugar, PPBS=Postprandial blood sugar, TC=Total cholesterol, TGs=Triglycerides, LDL=Low-density lipoprotein, HDL=High-density lipoprotein, BDI=Beck Depression Inventory, D-QOL=Diabetes Quality of Life, SSI=Spielberger’s state anxiety inventory, STAI=Spielberger’s trait anxiety inventory
Mean changes with standard deviation in the yoga group for variables tested at baseline and 3 months of intervention
| Variables | Baseline | CI | 3 months | CI | ||
|---|---|---|---|---|---|---|
| HbA1c | 8.6±0.6 | 8.5-8.7 | 8.1±0.7 | 8.0-8.2 | 71.5 | <0.05 |
| SSAI | 37.5±6.7 | 36.1-38.8 | 29.6±9.9 | 27.6-31.6 | 95.7 | <0.05 |
| STAI | 32.4±6.5 | 31.1-33.7 | 28.0±7.1 | 26.5-29.4 | 19.7 | <0.05 |
| Total anxiety | 69.9±8.2 | 68.2-71.6 | 57.6±10.5 | 55.5-59.8 | 121.5 | <0.05 |
| BDI | 23.2±4.3 | 22.3-24.0 | 14.5±2.3 | 14.0-15.0 | 531.8 | <0.05 |
| Self-efficacy | 31.1±9.9 | 29.0-33.1 | 50.3±7.0 | 48.9-51.7 | 321.5 | <0.05 |
| D-QOL | 46.9±5.4 | 45.8-48.0 | 70.7±7.4 | 69.2-72.2 | 502.6 | <0.05 |
HbA1c=Glycated hemoglobin, SSAI=Spielberger’s State Anxiety Inventory, STAI=Spielberger’s Trait Anxiety Inventory, total anxiety=Sum total of state and trait anxiety as mentioned by Spielberger, BDI=Beck Depression Inventory, D-QOL=Diabetes Quality of Life, Self-efficacy=Exercise Self-Efficacy Scale, CI=Confidence interval
Mean changes with standard deviation in the exercise group for variables tested at baseline and 3 months of intervention
| Variables | Baseline | CI | 3 months | CI | ||
|---|---|---|---|---|---|---|
| HbA1c | 7.7±1.0 | 7.5-7.9 | 7.4±1.0 | 7.2-7.7 | 18.2 | <0.05 |
| SSAI | 32.0±10.2 | 29.8-34.1 | 28.9±10.2 | 26.8-31.1 | 4.7 | <0.05 |
| STAI | 24.7±8.2 | 23.0-26.4 | 23.7±6.0 | 22.4-25.0 | 4.8 | <0.05 |
| Total anxiety | 56.7±12.8 | 54.1-59.4 | 52.7±12.1 | 50.1-55.2 | 8.7 | <0.05 |
| BDI | 24.8±4.8 | 23.8-25.8 | 20.8±3.2 | 20.1-21.5 | 124.7 | <0.05 |
| Self-efficacy | 35.2±9.6 | 33.1-37.2 | 37.4±7.0 | 35.9-38.9 | 106.1 | <0.05 |
| D-QOL | 48.5±8.2 | 46.8-50.3 | 51.6±10.0 | 49.5-53.7 | 27.0 | <0.05 |
HbA1c=Glycated hemoglobin, SSAI=Spielberger’s State Anxiety Inventory, STAI=Spielberger’s Trait Anxiety Inventory, total anxiety=Sum total of state and trait anxiety as mentioned by Spielberger. BDI=Beck Depression Inventory, D-QOL=Diabetes Quality of Life, Self efficacy=Exercise Self-Efficacy Scale, CI=Confidence interval
Comparison of changes across both the groups in terms of mean difference with standard error
| Variables | Yoga group | Exercise group | ||||||
|---|---|---|---|---|---|---|---|---|
| MD | SE | MD | SE | |||||
| HbA1c | 0.47 | 0.12 | <0.05 | 0.28 | 0.13 | <0.05 | 34.4 | <0.05 |
| SSAI | 7.8 | 1.3 | <0.05 | 3.0 | 1.3 | >0.05 | 27.1 | <0.05 |
| STAI | 4.4 | 1.14 | <0.05 | 1.0 | 1.18 | >0.05 | 24.8 | <0.05 |
| Total anxiety | 12.2 | 1.70 | <0.05 | 4.0 | 1.76 | >0.05 | 44.7 | <0.05 |
| BDI | 8.6 | 0.45 | <0.05 | 4.0 | 0.46 | <0.05 | 312.6 | <0.05 |
| ESE | 19.2 | 1.35 | <0.05 | 2.2 | 1.39 | >0.05 | 171.4 | <0.05 |
| D-QOL | 23.7 | 1.25 | <0.05 | 3.0 | 1.3 | >0.05 | 116.7 | <0.05 |
F=Interaction effect computation of ANOVA across groups, HbA1c=Glycated hemoglobin, SSAI=Spielberger’s State Anxiety Inventory, STAI=Spielberger’s Trait Anxiety Inventory, total anxiety=Sum total of state and trait anxiety as mentioned by Spielberger. BDI=Beck Depression Inventory, D-QOL=Diabetes Quality of Life, Self efficacy=Exercise Self-Efficacy Scale, MD=Mean difference, SE=Standard error